Thyroid hormone resistance is an inherited condition in which the body’s tissues respond poorly to thyroid hormone, even though the hormone is present at higher-than-normal levels in the blood. People with this condition typically show elevated free T3 and free T4 alongside a thyroid-stimulating hormone (TSH) level that remains normal or even elevated, a combination that confuses standard thyroid testing because, in most thyroid disorders, high hormone levels push TSH down.1PubMed Central. Update on resistance to thyroid hormone syndromeβ The condition is caused by mutations in thyroid hormone receptor genes and varies so widely in its effects that some people never realize they have it, while others face significant symptoms from childhood onward.
How Thyroid Hormone Resistance Works
Thyroid hormone does its job by entering cells and binding to receptor proteins inside the nucleus. These receptors sit on stretches of DNA and, once activated by the hormone, switch genes on or off. In thyroid hormone resistance, mutations alter the receptor so that it can still attach to DNA but can no longer respond properly to the hormone. The result is a receptor that occupies the site where a working receptor should be, blocking it from doing its job.2PubMed. Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone
This “dominant negative” effect is the reason most cases follow an autosomal dominant inheritance pattern, meaning you only need one copy of the faulty gene (inherited from one parent) to develop the condition. The mutant receptor doesn’t just sit there doing nothing; it actively interferes with the normal receptor’s ability to activate hormone-responsive genes.3PubMed. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone The body tries to compensate by ramping up thyroid hormone production, which is why blood levels of T3 and T4 climb. TSH stays inappropriately normal or high because the pituitary gland, which would normally sense the excess and dial back, is itself partly resistant to the hormone.
The Two Main Genetic Forms
The most common type, called RTHβ, is caused by mutations in the THRB gene, which encodes the beta form of the thyroid hormone receptor.4PubMed Central. Resistance to Thyroid Hormone Beta: A Focused Review Beta receptors are concentrated in the pituitary, liver, and kidneys, so the effects of RTHβ tend to be most obvious in those tissues. Most identified families with thyroid hormone resistance carry a THRB mutation, and hundreds of different mutations have been catalogued across the gene’s hormone-binding domain.
A much rarer form, RTHα, involves mutations in the THRA gene, which codes for the alpha receptor. Alpha receptors are more abundant in the brain, heart, bone, and gastrointestinal tract. People with RTHα tend to have a different clinical picture: growth and developmental delays are more prominent, and the standard thyroid blood tests can look nearly normal because the pituitary (dominated by beta receptors) is not involved in the same way.5The Lancet Diabetes & Endocrinology. Resistance to thyroid hormone mediated by defective thyroid hormone receptor α1 The tissue-specific distribution of each receptor type is what determines which organs are most affected in each form of resistance.6PubMed Central. A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms
Symptoms in RTHβ
The clinical picture of RTHβ is famously unpredictable. Two members of the same family carrying the identical mutation can present very differently.7PubMed. The variable clinical phenotype in thyroid hormone resistance syndrome That said, certain features come up repeatedly across affected individuals.
Goiter, or thyroid gland enlargement, is one of the most visible signs. It develops because TSH keeps stimulating the thyroid to make more hormone, and the gland grows in response to this constant demand.8PubMed. Regression of a large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine In some people the goiter is modest, in others it becomes large enough to be cosmetically noticeable or to cause pressure symptoms in the neck.
Attention deficit-hyperactivity disorder is strikingly common in children with RTHβ. In one study comparing children with resistance to their unaffected siblings, about 70 percent of the resistant children met criteria for ADHD, compared to 20 percent of those without the mutation.9PubMed. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone Whether this reflects a direct effect of abnormal thyroid signaling in the developing brain or an indirect consequence of the hormonal milieu is still debated, but the association is strong enough that thyroid hormone resistance is sometimes first suspected when a child with ADHD turns out to have unusual thyroid labs.
The heart responds to thyroid hormone mainly through alpha receptors, so in people with RTHβ the heart may “see” the elevated hormone levels more or less normally while other tissues remain resistant. This creates a paradox: someone with RTHβ can experience a fast heart rate and palpitations (signs the heart is overstimulated) at the same time their liver and brain are functionally hypothyroid. Studies of cardiac function in RTHβ patients show a modulated hyperthyroid effect on the heart, with changes that are milder than those seen in conventional hyperthyroidism but still measurable.10PubMed. Cardiac involvement in thyroid hormone resistance
Growth can also be affected. Research on a large family with a shared THRB mutation found that bone maturation was delayed in affected children, and both children and adults with the condition were shorter than their unaffected relatives, suggesting that skeletal tissue hypothyroidism leads to permanent growth retardation.11PubMed. Retarded bone growth in thyroid hormone resistance. A clinical study of a large family with a novel thyroid hormone receptor mutation
How RTHα Symptoms Differ
Because alpha receptors dominate in the brain, heart, bone, and gut, RTHα tends to cause constipation, intellectual disability or learning difficulties, slowed growth, and sometimes a characteristically low metabolic rate. The cardiac picture is interesting: when RTHα patients were given high-dose thyroxine to try to overcome the resistance, their metabolic rate climbed from well below normal toward higher levels, yet their heart rate did not increase the way it would in a person with conventional excess thyroid hormone. This suggests the heart in RTHα may itself be partly resistant to thyroid-driven speeding up.12PubMed Central. Resistance to thyroid hormone induced tachycardia in RTHα syndrome
RTHα is much harder to pick up on routine bloodwork. Because the pituitary’s beta receptors are intact, TSH regulation works roughly as expected, and free T4 may sit within the normal range. In practice, this means many RTHα cases are diagnosed only after genetic testing is prompted by the characteristic clinical features rather than by a surprising lab result.
Why It Gets Misdiagnosed
The combination of elevated thyroid hormones and a non-suppressed TSH doesn’t fit the usual patterns doctors are trained to recognize. In standard hyperthyroidism, such as Graves’ disease, the excess hormone drives TSH essentially to zero. When a lab report comes back showing high T3 and T4 but a normal or elevated TSH, two main possibilities arise: a TSH-secreting pituitary tumor (TSHoma) or thyroid hormone resistance. Confusing these with each other, or with conventional hyperthyroidism, leads to treatment choices that can make things worse.
Misdiagnosis is a real clinical problem. Patients with RTHβ have been mistakenly treated with anti-thyroid drugs or even had their thyroid glands surgically removed or ablated with radioactive iodine.13PubMed Central. A case of thyroid hormone resistance with thyroid regrowth: implications of misdiagnosis on patient care Destroying the thyroid in someone with RTHβ is counterproductive: their tissues are already struggling to respond to thyroid hormone, and removing the gland eliminates whatever compensatory hormone production the body was managing. The result is worsening hypothyroid symptoms in the tissues that rely on beta receptors, without solving the problem in the tissues that were already relatively overstimulated.14Military Medicine. Diagnosis of Resistance to Thyroid Hormone due to a Rare Mutation in the Thyroid Hormone Receptor Beta Gene in a Patient Previously Presumed to Have Graves’ Disease
How Doctors Tell It Apart from a TSH-Secreting Tumor
Distinguishing RTHβ from a TSH-secreting pituitary adenoma (TSHoma) matters enormously because the treatment paths are completely different: a TSHoma typically requires surgery, while RTHβ usually requires no intervention at all. Several tests help sort this out.
The thyrotropin-releasing hormone (TRH) stimulation test is a key tool. When TRH is injected, a patient with RTHβ typically shows a normal rise in TSH, whereas someone with a TSHoma usually shows a flat, blunted response.15Annals of Pediatric Endocrinology & Metabolism. Resistance to thyroid hormone and nonfunctioning pituitary microadenoma in a 13-year-old boy with THRB mutation Similarly, the glycoprotein hormone alpha-subunit level and its ratio to TSH tend to be elevated in TSHoma but normal in RTHβ. In a somatostatin suppression test, a TSHoma’s TSH often drops dramatically, while RTH patients respond less predictably.16PubMed Central. TSH adenoma and syndrome of resistance to thyroid hormones—Two cases report of syndrome of inappropriate secretion of thyrotropin
Adding to the difficulty, some patients have both conditions. Case reports describe individuals with a confirmed THRB mutation who also have a coincidental pituitary microadenoma, making the biochemical picture even harder to interpret.17PubMed Central. Challenging diagnosis of resistance to thyroid hormone in a patient with pituitary adenoma Genetic testing for THRB mutations has become the definitive way to confirm RTHβ when the clinical and biochemical picture is ambiguous.
Treatment and When It Is Actually Needed
Most people with RTHβ do not need treatment. The elevated thyroid hormone levels are the body’s way of compensating for tissue resistance, and the compensation often works well enough that the person functions normally. Interfering with that balance, whether by blocking hormone production or destroying the gland, tends to create new problems rather than solving existing ones.
Treatment becomes relevant when the compensatory hormone excess causes symptoms in tissues that are relatively less resistant, particularly the heart. If someone with RTHβ has a fast resting heart rate, palpitations, or anxiety related to cardiac overstimulation, beta-blockers can help manage those specific symptoms without disrupting the overall thyroid economy.
For more comprehensive symptom relief, a thyroid hormone analogue called TRIAC (triiodothyroacetic acid) has shown promise. TRIAC preferentially activates the beta receptor and can suppress TSH secretion, which in turn brings circulating T4 and T3 levels closer to normal. In a clinical study of eight patients, TRIAC therapy significantly lowered their hyperthyroid symptom scores, normalized free T4 levels, and reduced total T3 concentrations, all without causing TSH to rise.18The Journal of Clinical Endocrinology & Metabolism. TRIAC Therapy Relieves Hyperthyroid Symptoms, Lowering T4, T3, and Metabolic Rate in Resistance to Thyroid Hormone β Some patients in that study found the best results from combining TRIAC with a beta-blocker, using the beta-blocker specifically for palpitations and tachycardia while TRIAC addressed other symptoms like heat intolerance and weight changes.
Earlier reports on TRIAC had mixed results. In some patients, the drug effectively suppressed TSH and lowered circulating T4 but did not reduce signs of thyroid hormone action in peripheral tissues, apparently because TRIAC’s own metabolic effects offset the benefit of lowering T4.19PubMed. 3,5,3′-triiodothyroacetic acid therapy for thyroid hormone resistance Adding propranolol to TRIAC has been reported to improve the clinical picture in cases where TRIAC alone was insufficient to control hyperthyroid-type symptoms.20PubMed. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3′ triiodothyroacetic associated to propranolol
For RTHα, the approach is different. Because the alpha receptor is the one that isn’t working, giving additional thyroid hormone (thyroxine) at supraphysiologic doses can sometimes push past the resistance in affected tissues. Patients treated this way have reported improved quality of life, and researchers are exploring whether partial replacement of standard thyroxine (T4) with T3 might further improve outcomes.21PubMed. Thyroxine Treatment of Adult RTHα Patients: Safety, Efficacy, and Metabolomic Changes
Pregnancy in Women with RTHβ
Pregnancy adds a layer of complexity. If a mother has RTHβ and her fetus does not carry the mutation, the fetus is exposed to the mother’s elevated thyroid hormone levels without having any resistance to buffer the effect. This can result in fetal thyrotoxicosis, low birth weight, and suppressed TSH at birth. Research shows that keeping the mother’s free T4 below about 50 percent above the upper limit of normal helps protect unaffected fetuses. When this target is maintained, birth weight and neonatal TSH are comparable between affected and unaffected babies.22PubMed Central. Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications
Prenatal genetic testing via chorionic villus sampling or amniocentesis can determine whether the fetus carries the THRB mutation, which helps guide management. If the fetus also has RTHβ, the elevated maternal hormone levels are less of a concern because the baby’s own tissues are similarly resistant. If the fetus is unaffected, closer monitoring and possibly dose adjustment become important.
Other Causes of Reduced Thyroid Hormone Sensitivity
Mutations in the thyroid hormone receptors are not the only way the body can become insensitive to thyroid hormone. Defects in the cellular machinery that transports or metabolizes the hormone can produce similar clinical syndromes with their own distinctive lab patterns.
Mutations in the MCT8 gene, which encodes a transporter that carries thyroid hormone into cells (especially in the brain), cause a severe neurodevelopmental syndrome in boys. Blood tests in affected individuals typically show high T3, low T4, low reverse T3, and normal or slightly elevated TSH. The neurological devastation is severe, often including intellectual disability and movement abnormalities. A separate condition involving mutations in the SBP2 gene, which is involved in how the body uses selenium to process thyroid hormone, produces a nearly mirror-image lab profile: low T3, high T4, and elevated reverse T3.23PubMed Central. Inherited defects in thyroid hormone cell-membrane transport and metabolism These are rarer than receptor-based resistance but worth knowing about because they illustrate that thyroid hormone sensitivity depends on a whole chain of events, from transport into cells to receptor binding to downstream gene activation, and a break at any link in that chain can cause trouble.
Why Symptoms Vary So Much Within Families
One of the most puzzling features of thyroid hormone resistance is its extreme variability. Two siblings carrying the exact same THRB mutation can end up on opposite ends of the clinical spectrum: one essentially asymptomatic, the other with a noticeable goiter, learning difficulties, and a fast heart rate.24International Journal of Thyroidology. A Case of Thyroid Hormone Resistance Syndrome Beta (RTHβ) Diagnosed in a 3-Year-Old Girl In fact, different clinical features have been observed in affected individuals within the same family harboring the same mutation, and identical mutations have appeared in unrelated families where some members were classified as having generalized resistance while others appeared to have predominantly pituitary resistance.7PubMed. The variable clinical phenotype in thyroid hormone resistance syndrome
This variability probably reflects the influence of other genetic factors that modify how the body handles thyroid hormone: differences in coactivator and corepressor proteins, variations in thyroid hormone transport, and the ratio of alpha to beta receptors in a given tissue. Environmental factors during development likely play a role as well. The practical consequence for families is that a parent with mild, easily managed RTHβ cannot assume their child will have the same experience, and affected children need individual assessment rather than assumptions based on a parent’s course.
The wide phenotypic range also explains why population estimates for thyroid hormone resistance vary so much. Many mildly affected individuals are never diagnosed, so the true prevalence is almost certainly higher than what published case counts suggest. Over 400 affected individuals had been identified by the mid-1990s, and the number has grown considerably since then as genetic testing has become more accessible and clinicians have become more aware of the diagnosis.25PubMed. Resistance to thyroid hormone: an historical overview Yet for every person who gets a genetic diagnosis, there are likely others whose mildly abnormal thyroid tests are shrugged off or attributed to lab error, especially if they have no prominent symptoms.